Resistance to pentamidine is mediated by AdeAB, regulated by AdeRS, and influenced by growth conditions in Acinetobacter baumannii ATCC 17978

PLoS One. 2018 May 11;13(5):e0197412. doi: 10.1371/journal.pone.0197412. eCollection 2018.

Abstract

In recent years, effective treatment of infections caused by Acinetobacter baumannii has become challenging due to the ability of the bacterium to acquire or up-regulate antimicrobial resistance determinants. Two component signal transduction systems are known to regulate expression of virulence factors including multidrug efflux pumps. Here, we investigated the role of the AdeRS two component signal transduction system in regulating the AdeAB efflux system, determined whether AdeA and/or AdeB can individually confer antimicrobial resistance, and explored the interplay between pentamidine resistance and growth conditions in A. baumannii ATCC 17978. Results identified that deletion of adeRS affected resistance towards chlorhexidine and 4',6-diamidino-2-phenylindole dihydrochloride, two previously defined AdeABC substrates, and also identified an 8-fold decrease in resistance to pentamidine. Examination of ΔadeA, ΔadeB and ΔadeAB cells augmented results seen for ΔadeRS and identified a set of dicationic AdeAB substrates. RNA-sequencing of ΔadeRS revealed transcription of 290 genes were ≥2-fold altered compared to the wildtype. Pentamidine shock significantly increased adeA expression in the wildtype, but decreased it in ΔadeRS, implying that AdeRS activates adeAB transcription in ATCC 17978. Investigation under multiple growth conditions, including the use of Biolog phenotypic microarrays, revealed resistance to pentamidine in ATCC 17978 and mutants could be altered by bioavailability of iron or utilization of different carbon sources. In conclusion, the results of this study provide evidence that AdeAB in ATCC 17978 can confer intrinsic resistance to a subset of dicationic compounds and in particular, resistance to pentamidine can be significantly altered depending on the growth conditions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acinetobacter Infections / drug therapy*
  • Acinetobacter baumannii / drug effects*
  • Acinetobacter baumannii / genetics
  • Anti-Bacterial Agents / pharmacology*
  • Bacterial Proteins / genetics
  • Bacterial Proteins / physiology*
  • Carbon / chemistry
  • Chelating Agents / chemistry
  • Computational Biology
  • Drug Resistance, Multiple, Bacterial / genetics*
  • Gene Deletion
  • Gene Expression Regulation, Bacterial
  • Genetic Complementation Test
  • Iron / chemistry
  • Membrane Transport Proteins / genetics
  • Membrane Transport Proteins / physiology*
  • Microbial Sensitivity Tests
  • Mutation
  • Oligonucleotide Array Sequence Analysis
  • Oxidation-Reduction
  • Pentamidine / pharmacology*
  • Phenotype
  • Sequence Analysis, RNA
  • Transcriptome

Substances

  • AdeA protein, Acinetobacter baumannii
  • AdeB protein, Acinetobacter baumannii
  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Chelating Agents
  • Membrane Transport Proteins
  • Pentamidine
  • Carbon
  • Iron

Grants and funding

This work was supported by the Australian National Health and Medical Research Council (Project Grant 1047509) and a Flinders Medical Research Foundation Grant to MHB and UHS. FGA was supported by AJ and IM Naylon and Playford Trust Ph.D. Scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.